Bisperoxovanadium, a phospho‐tyrosine phosphatase inhibitor, reprograms myogenic cells to acquire a pluripotent, circulating phenotypeLaura Castaldi, Marina Bouché, Mario Molinaro et al.|The FASEB Journal|2007Cited by 19